The International Society for Pharmaceutical Engineering (ISPE) announces that the Project Management Institute (PMI), the world’s largest project management member association, has named it as a Registered Education Provider (R.E.P.) effective October 31, 2012.
R.E.P.s are organizations that have been approved by PMI to help project managers achieve and maintain the Project Management Professional (PMP), Program Management Professional (PgMP), and other PMI professional credentials. These organizations have met PMI’s rigorous quality criteria for course content, instructor qualification, and instructional design.
Project managers are increasingly turning to R.E.P.s for certification training and maintenance, especially since median salaries for the profession now exceed $100,000.
The ISPE Training Department’s mission is to develop high quality, topic-specific, in-depth training products in a variety of delivery methods. This includes the identification, development, delivery, and continuous improvement of global classroom and online training products encompassing the pharmaceutical supply chain emphasize new manufacturing science, quality and regulatory compliance, and alignment with the Society’s Strategic Plan to meet the needs of global pharmaceutical manufacturing industry professionals.
“We are pleased to be identified as a PMI Registered Education Provider for our Facility Project Management in the Regulated Pharmaceutical industry training course,” said ISPE president and CEO Nancy Berg. “This designation is especially important to our pharmaceutical industry members whose product quality is driven in part by exemplary project management skills. Partnering with PMI enhances ISPE’s world-class programs and gives us a benchmark distinction that is recognized globally and across industries.”
ISPE joins more than 1500 R.E.P.s in more than 80 countries. These organizations include commercial training providers, academic institutions, and corporate training departments within corporations and government agencies.
ISPE is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, FL, and offices in Brussels, Belgium, Singapore, and Shanghai, China. Visit www.ISPE.org for more information.